Suppliers / Gemini PharmChem Mannheim

Gemini PharmChem Mannheim

Germany 26 employees Updated 9 July 2026

Gemini PharmChem Mannheim is an API manufacturer based in Germany. Its GMP standing is certified by ZLG (DE). Its most recent recorded inspection, by US FDA, closed on 21 January 2022 as VAI.

0
active US DMFs
0
valid CEPs
2
registered plants 1 with an FDA FEI number
0
filings across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 21 January 2022 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Germany, Germany 3014000756
Mannheim, Germany Not on file

What they file, and where

Molecule Regulators Docs
Doxorubicin SFDA (Saudi Arabia) 1

Also appears on these molecule pages

Doxorubicin API

Filings and GMP by regulator

Regulator Filings GMP certificates
ZLG (DE) None 14

Questions about Gemini PharmChem Mannheim

Is Gemini PharmChem Mannheim FDA-registered?
One site operated by Gemini PharmChem Mannheim carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did Gemini PharmChem Mannheim's last inspection go?
The most recent inspection on record closed on 21 January 2022 as VAI (Voluntary Action Indicated: issues were found but did not warrant regulatory action). 1 inspection is on file.
Where does Gemini PharmChem Mannheim manufacture?
2 registered sites are on record, in Germany (Germany and Mannheim). Every site is listed on this page with the register it came from.
What does Gemini PharmChem Mannheim make?
1 molecule is on record against Gemini PharmChem Mannheim, including Doxorubicin. Each links through to that molecule's full manufacturer list.
Which regulators recognise Gemini PharmChem Mannheim's GMP?
Current GMP certificates are on record from ZLG (DE). GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Gemini PharmChem Mannheim comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 21 January 2022.

Comparable suppliers

Olon shares 1 molecule Hisun Pharmaceutical shares 1 molecule Dzd (Heze) Pharmaceutical shares 1 molecule Synbias Pharma shares 1 molecule MicroBiopharm Japan shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates